+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 65Years
All Genders
ID05011266

Study of Buprenorphine-Naloxone Added to Extended Release Naltrexone for Preventing Relapse in Adults with Opioid Use Disorder

Led by New York State Psychiatric Institute · Updated on 2026-05-19

180

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new approach to improve treatment for individuals with opioid use disorder by combining extended release naltrexone XR-naltrexone with buprenorphine-naloxone. The study aims to see if adding buprenorphine-naloxone can help reduce opioid cravings, improve mood, and increase how long people stay on XR-naltrexone treatment. This is a phase 23, double-blind, placebo-controlled trial involving adults aged 18 to 65 with opioid use disorder. Participants will receive XR-naltrexone injections every four weeks for 24 weeks, totaling six doses. After the first XR-naltrexone injection, they will be randomly assigned to take either buprenorphine-naloxone sublingual tablets daily or a placebo. The buprenorphine-naloxone dose will start after the initial XR-naltrexone injection and be gradually tapered off by the end of the study. Weekly medication management visits are included to monitor treatment. During the study, participants will undergo detoxification if needed and receive their first XR-naltrexone injection before randomization. Researchers will monitor treatment retention by measuring the proportion of participants receiving XR-naltrexone injections at 20 weeks. Assessments include medical history, physical exams, laboratory tests, and mood evaluations. The total study participation lasts 24 weeks, with careful monitoring throughout the treatment period.

CONDITIONS

Brief Title

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Research Team

A

Adam Bisaga, MD

O

Onumara Opara, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here